Patents by Inventor SATOSHI ABURATANI

SATOSHI ABURATANI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical preparation comprising phenylalanine derivative
    Patent number: 10166234
    Abstract: The disclosed pharmaceutical preparation comprises a compound represented by the chemical formula (A) or a pharmaceutically acceptable salt thereof, which is dispersed in a matrix consisting of a water-soluble high molecular weight substance; and Crospovidone: The pharmaceutical preparation is excellent in the solubility and the storage stability even if the amount of the compound or the salt included in each individual dosage unit is increased.
    Type: Grant
    Filed: May 30, 2018
    Date of Patent: January 1, 2019
    Assignee: EA Pharma Co., Ltd.
    Inventors: Satoshi Aburatani, Hirokazu Hagio, Hiroyuki Higuchi, Kenichi Ogawa
  • PHARMACEUTICAL PREPARATION COMPRISING PHENYLALANINE DERIVATIVE
    Publication number: 20180271868
    Abstract: The disclosed pharmaceutical preparation comprises a compound represented by the chemical formula (A) or a pharmaceutically acceptable salt thereof, which is dispersed in a matrix consisting of a water-soluble high molecular weight substance; and Crospovidone: The pharmaceutical preparation is excellent in the solubility and the storage stability even if the amount of the compound or the salt included in each individual dosage unit is increased.
    Type: Application
    Filed: May 30, 2018
    Publication date: September 27, 2018
    Applicant: EA Pharma Co., Ltd.
    Inventors: Satoshi ABURATANI, Hirokazu HAGIO, Hiroyuki HIGUCHI, Kenichi OGAWA
  • Pharmaceutical preparation comprising phenylalanine derivative
    Patent number: 10039763
    Abstract: The disclosed pharmaceutical preparation comprises a compound represented by the chemical formula (A) or a pharmaceutically acceptable salt thereof, which is dispersed in a matrix consisting of a water-soluble high molecular weight substance; and Crospovidone: The pharmaceutical preparation is excellent in the solubility and the storage stability even if the amount of the compound or the salt included in each individual dosage unit is increased.
    Type: Grant
    Filed: October 1, 2012
    Date of Patent: August 7, 2018
    Assignee: EA Pharma Co., Ltd.
    Inventors: Satoshi Aburatani, Hirokazu Hagio, Hiroyuki Higuchi, Kenichi Ogawa
  • PHARMACEUTICAL PREPARATION COMPRISING PHENYLALANINE DERIVATIVE
    Publication number: 20160082009
    Abstract: The disclosed pharmaceutical preparation comprises a compound represented by the chemical formula (A) or a pharmaceutically acceptable salt thereof, which is dispersed in a matrix consisting of a water-soluble high molecular weight substance; and Crospovidone: The pharmaceutical preparation is excellent in the solubility and the storage stability even if the amount of the compound or the salt included in each individual dosage unit is increased.
    Type: Application
    Filed: November 30, 2015
    Publication date: March 24, 2016
    Applicant: AJINOMOTO CO., INC.
    Inventors: SATOSHI ABURATANI, HIROKAZU HAGIO, HIROYUKI HIGUCHI, KENICHI OGAWA